drugset / Trial / NCT04939545

Study of Postoperative ICC Analgesia

NCT04939545

Phase 3 Completed 32 enrolled University Hospital, Basel, Switzerland
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is to examine the analgesic effectiveness of continuous loco-regional analgesic application (ropivacaine) through surgically placed Intercostal Catheter (ICC) and to establish correctly this method as a possible standard of care in the postoperative analgesia after Video-assisted thoracoscopic surgery (VATS) anatomical lung resection.

Timeline

Start
2021-12-15
Primary completion
2023-03-20
Completion
2023-10-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Ropivacaine Other / unclassified 2 mg/ml Other

Indications

No indication recorded.